Request Deal Involvement
Santen Holdings completed the acquisition of Eyevance Pharmaceuticals Holdings for $225m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Nomura
legal advisors
Mayer Brown
pr advisors
Corporate Communications
legal advisors
Morrison Foerster
financial advisors
Torreya Capital
or
Principals
target
EYEVANCE PHARMACEUTICALS
bidder
SANTEN PHARMACEUTICAL
bidder
SANTEN HOLDINGS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite